Home »
The EU’s medicines regulator on Friday gave the green light for the first injectable treatment for the HIV virus that causes AIDS, which could change the lives of millions of people. The cocktail of two
Ah, our first kiss. Your memories may be conjure up vivid scenes ranging from sweet, dramatic, embarrassing to entirely lackluster. Some of the details such as where we were, who the smooch was with and
DNA usually forms the classic double helix shape discovered in 1953—two strands wound around each other. Several other structures have been formed in test tubes, but this does not necessarily mean they form within living
A team from Lawson Health Research Institute and Western University are the first in the world to profile the body’s immune response to COVID-19. By studying blood samples from critically ill patients at London Health
Among the enduring images from our days of COVID-19 is this: A patient, having survived the disease on a respirator and now free of symptoms, is wheeled from the hospital through a phalanx of exuberant
Kara Keough revealed on Sunday, May 24, that she got her first tattoo in honor of her son, McCoy, who died in childbirth. The Real Housewives of Orange County alum, 31, shared a photo on
Your essential guide for what to do in an emergency – as research suggests 40 per cent of Britons would be worried about giving first aid Most basic of first aid knowledge could be the
Mount Sinai researchers are the first in the country to use artificial intelligence (AI) combined with imaging, and clinical data to analyze patients with coronavirus disease (COVID-19). They have developed a unique algorithm that can
Cardiff University researchers are part of a global consortium who have published the first clinical guidance for the management of Huntington’s disease through physiotherapy. It follows more than a decade of ground-breaking collaborative research led
A pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer, a new clinical trial shows. The phase II trial found